PharmAthene, Inc. Reports Third Quarter 2009 Financial and Operational Results
11/13/2009 9:17:24 AM
More...
|
PharmAthene, Inc. Reports Third Quarter 2009 Financial and Operational Results
11/12/2009 12:23:38 PM
More...
|
PharmAthene, Inc. To Host Third Quarter 2009 Conference Call and Webcast on Thursday, November 12, 2009
11/3/2009 9:48:05 AM
More...
|
PharmAthene, Inc. Presents Data for Valortim(R) Anthrax Anti-Toxin and Third Generation rPA Anthrax Vaccine Programs at the Bacillus - ACT 2009 Conference
9/3/2009 3:04:48 PM
More...
|
PharmAthene, Inc. to Present at the Rodman & Renshaw Annual Global Investment Conference September 10, 2009
9/1/2009 11:15:16 AM
More...
|
PharmAthene, Inc. Strengthens Senior Management Team; Appoints Charles A. Reinhart III Senior Vice President, Chief Financial Officer
8/17/2009 11:21:31 AM
More...
|
PharmAthene, Inc. Reports Second Quarter 2009 Financial and Operational Results Recent Financing Strengthens Balance Sheet and Eliminates Short Term Debt
8/13/2009 8:09:59 AM
More...
|
PharmAthene, Inc. to Host Second Quarter 2009 Conference Call and Webcast on Thursday, August 13, 2009
8/6/2009 11:33:24 AM
More...
|
PharmAthene, Inc. Announces $19.3 Million Private Placement of Convertible Notes and Common Stock Warrants
7/27/2009 9:00:00 AM
More...
|
PharmAthene, Inc.'s 2nd Generation rPA Anthrax Vaccine, SparVax(TM), Completes FDA Regulatory Strategy Review
7/10/2009 8:19:30 AM
More...
|
|